IN FOCUS FEATURE
Teachers Head to San Diego for Sun, Fun and Biotechnology
FROM OUR WEB SITE
 |
| Since March 2006, North Carolina's biotechnology industry has grown by 24 percent. |
From Our Web Site
Mooresville Firm Gets Superbug OK
A disinfectant/sanitizer product made by EnviroSystems has received approval for use against an additional type of bacterium.
Biogen Idec and BioNetwork Create Scholarship
A $25,000 donation will help students who are pursuing two-year degrees in the life sciences.
Banner Pharmacaps Receives FDA Approval for Drug
The U.S. Food and Drug Administration granted approval for the High Point company to produce a generic version of a flu-symptom treatment.
CED Picks Joan Siefert Rose as Monica Doss' Successor
Broadcast executive Joan Siefert Rose will be the next president of the Council for Entrepreneurial Development.
UNC-CH Lands $61M Grant
A $61M federally-funded health initiative to speed benefits of science to North Carolinians.
Raleigh's INC Research Adds Focus on Women's Health
Drug development issues unique to women will be the focus of the company's new team.
In Focus
Teachers Head to San Diego for Sun, Fun and Biotechnology
Three North Carolina high school science teachers plan to visit San Diego next week to participate in a conference specifically for biotechnology education. The Biotechnology Institute's Teacher-Leader program awarded the trip to these educators.
In this week's In Focus, read Katie Trapp's profile of the three extraordinary teachers that will get this opportunity.
News from Other Sites
Adherex Announces Updated ADH-1 Chemotherapy Combination Data in Melanoma
This biopharmaceutical company, dedicated to solving problems for patients with cancer, announced results from its ongoing Phase I/II study of a combination treatment for melanoma.
From FoxBusiness.com
Addrenex aims for fast track: Relatively Young for Drug Company, it Plans to Create Drugs to Counter Adrenaline
Bucking the current trend of outsourcing, this company keeps development work in-house. That includes designing, managing and tracking trials, talking to the Food and Drug Administration and writing regulatory requests for the approval of new drugs.
From the (Raleigh) News & Observer
Bandage is Built to Slow Bleeding
A Winston-Salem company is one of the manufacturers for an innovative fabric used to help consumers, particularly emergency responders in treating the heavy bleeding they often see.
From the Winston-Salem Journal
N.C. Firm Gets FDA Go Ahead for Bandage
Entegrion Inc., a biomedical group based in North Carolina's Research Triangle Park, has received clearance from the Food and Drug Administration for over-the-counter sales of its fabric, Stasilon.
From the Scripps Howard News Service
NIH Expands National Consortium Dedicated to Transforming Clinical and Translational Research
North Carolina already has one CTSA consortium at Duke, and now one has been added at UNC-CH. Only 38 have been opened to date nationwide.
From States News Service
Owners Might Sell Talecris Instead of Pursuing an IPO
The investment firms that own Talecris Biotherapeutics, one of the Triangle's most successful biotechnology companies, may be considering a sale of the business rather than risking a hostile reception on Wall Street.
From the (Raleigh) News & Observer
State Needs to Help Address Needs
The North Carolina Center for Public Policy Research has released its newest findings and recommendations regarding the increasing shortage of nurses, teachers and biotechnology workers.
From The Mount Airy News
UNC Grant Will Help Hasten Medical Research
Thanks to a $61 million grant, UNC-Chapel Hill will be working to make sure families across North Carolina can tap into better care.
From the (Raleigh) News & Observer
Community Watch
- Gov. Mike Easley has appointed Ken Harewood, a member of the North Carolina Biotechnology Center board of directors, to the North Carolina Board of Science and Technology. Harewood is director of Biomedical/Biotechnology Institute at North Carolina Central University and is a GlaxoSmithKline Endowed Professor.
- PharmaLinkFHI, Inc. announced that it has appointed Frank Santoro, MD as Chief Medical Officer. Dr. Santoro joins PharmaLink from Protherics, a UK-based biopharmaceutical company specializing in oncology and critical care products where he served as Vice President, Clinical Development and Medical Affairs.
Please send Community Watch items to Jim Shamp.
Save the Date
June 17-20
BIO 2008 Conference
NC Pavilion Sponsorship
(San Diego)
Dec. 4-5
SE Bio Investor Forum
(Palm Beach, Fla.)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, June 5, 2008. For the latest headlines from North Carolina's biotechnology industry, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.